FGF21 and Hyperglycemia: Both transgenic overexpression and exogenous administration of supraphysiologic levels of FGF21 in genetic- or diet-induced obese (DIO) rodents, substantially reduces body weight, hypertriglyceridaemia and hyperglycaemia [41,70,71].